Equifax Inc. (NYSE: EFX) — Priced as a Broken Cyclical, Still Compounding Like a Franchise
Independent fundamental research · Report date: 2026-06-27 · Price reference: $158.48 (2026-06-26)
⚡ Claude’s Take
This block is the author’s own independent opinion and general information only — not investment advice and not a recommendation to buy or sell any security. Everything below it (the analytical body) is deliberately position-free and carries no price target.
Verdict: HOLD with a constructive bias — accumulate-on-weakness into the ~$140–$155 zone (~16–18x FY26E adjusted EPS of ~$8.50 / ~12–13x EV/EBITDA); not a short here. Conviction: medium. Directional fair-value zone ~$185–$220 on a normalizing cycle and a partial re-rate.
Equifax is the rare situation where the tape and the income statement point in opposite directions, and that is the whole opportunity. The stock is down ~47% from its September-2024 high of $302 and ~38% over the trailing twelve months — a genuine falling knife with negative risk-adjusted returns at every horizon — yet it just printed Q1-2026 revenue +14%, organic constant-currency growth of +13% (200bps above its own framework), and adjusted EPS +22%, and management said it “would have raised” full-year guidance but for geopolitical caution. The de-rate is happening into accelerating numbers, not collapsing ones. On its own decade of history EFX sits at the 9.8th valuation percentile (P/S at the 0.66th), and at ~13x EV/EBITDA it trades ~8–10 turns below Moody’s, S&P Global, and Verisk — businesses it resembles, anchored by a crown-jewel Workforce Solutions segment growing double digits at a 44% operating margin. A reverse-DCF says the market is underwriting roughly low-single-digit perpetual growth and no multiple recovery — i.e., it has decided Workforce Solutions’ deceleration is structural and the mortgage depression is permanent. My scenario work puts the bear case at ~$139 (essentially spot), the base at ~$196, and the bull at ~$260: the price already embeds the bear, and the asymmetry is positive.
So why only a HOLD-with-a-bias rather than a table-pounding buy? Three things keep me honest. First, this is a falling knife with no technical floor — negative momentum and a high 1.40 beta mean only a fundamental catalyst (a mortgage turn or a durable Workforce re-acceleration) reverses it, and there is no penalty for waiting for one. Second, the crown jewel is contested: Equifax’s own 10-K calls verification “highly competitive with low barriers to entry,” and Experian is replicating The Work Number’s payroll-contributor playbook with Experian Verify while CFPB civil investigative demands probe the franchise directly. Third, the quality is real but levered and goodwill-heavy — ~2.7x net debt, negative tangible book, ~$6.7B of acquisition goodwill, and an ~8% consolidated ROIC that sits roughly at the cost of capital, the bill for richly-priced 2021 M&A. The framing is abandoned-quality-compounder / contrarian-value with one structural “if” — the Workforce moat — not a clean compounder and not a pure cyclical. Flips decisively bullish if Verification organic growth holds low-double-digits for another two to three quarters while mortgage stays weak (proving the diversified government/consumer-lending/talent engine, not just mortgage, is driving it) and free cash flow clears ~$1.2B at >100% conversion. Flips bearish if Verification decelerates toward mid-single-digits with evidence of Experian-Verify hit-rate parity, or if a mortgage-rate-cut cycle comes and goes without the latent refi pool converting. One uncomfortable tell sharpens the caution: across an 18-month Form 4 corpus, insiders logged exactly one open-market purchase against 54 sales, and the CEO bought nothing through a 47% drawdown. Cheap, accelerating, and abandoned — but not yet vindicated.
📈 Stock Price Action — Five-Year Event Map
Factual price history and attributed drivers. The price move is a Fact; the cause is Interpretation. No recommendation or price target here — that is the block above.
The arc. Over five years EFX ran from a COVID-era base near ~$185 (year-end 2020) to an all-time high of $302.01 (2024-09-13), then round-tripped almost the entire move: it closed 2025 at $215.70 and has since fallen to $158.48, just off its 52-week low of $151.93 (2026-06-25) and ~47.5% off the ATH, ~38% over the trailing twelve months. The stock trades well below its 200-day EMA (~$195.6), with a 52-week range of $151.93–$262.95. In short: the market took EFX from secular-compounder pricing back to cyclical-bureau pricing.
| # | Period | Approx. move | Price (~from → to) | Primary driver(s) | Fact / Interp |
|---|---|---|---|---|---|
| 1 | 2020 → end-2021 | +~53% | ~$185 → ~$283 | Post-COVID re-rate; refi/mortgage boom + Workforce Solutions secular-growth narrative; growth-multiple peak. | Fact / Interp |
| 2 | Jan → Oct 2022 | −~48% | ~$283 → $145.9 | Rate-shock bear market + mortgage-volume collapse; de-rating of all long-duration growth (5yr low 2022-10-20). | Fact / Interp |
| 3 | Late 2022 → 2023 | +~67% | $145.9 → ~$242 | Recovery rally; Workforce resilience + “cloud nearly done / margin inflection” narrative re-rated the stock. | Fact / Interp |
| 4 | 2024 → Sep 2024 | +~25% | ~$242 → $302.01 | New all-time high; AI-data-platform optimism + Fed-cut / mortgage-recovery hopes priced as a compounder. | Fact / Interp |
| 5 | Sep 2024 → mid-2025 | −~13% | $302 → ~$263 | Topping; mortgage recovery slower than hoped; stretched multiple meets decelerating mortgage prints. | Fact / Interp |
| 6 | Jul 2025 → Q4 2025 | −~18% | $262.95 → ~$216 | 52wk high 2025-07-09 then slide; Q2’25 guide held-despite-beat + EWS cut + higher litigation costs; hiring slowdown; Experian-Verify fears. | Fact / Interp |
| 7 | Q1 → Jun 2026 | −~27% | ~$216 → $158.48 | Continued de-rate despite a STRONG Q1’26 print (+14% rev, +22% adj EPS); guide held (not raised) on Iran-conflict caution; falling-knife tape. | Fact / Interp |
Cycle narrative. (1–2) EFX rode the 2020–21 mortgage/refi boom and growth-multiple euphoria to ~$283, then gave half of it back in the 2022 rate shock as mortgage volumes collapsed and the market de-rated every long-duration compounder. (3–4) The 2023–24 recovery was driven by Workforce Solutions’ resilience and the “EFX Cloud is nearly complete, margins and FCF inflect” thesis, carrying the stock to a fresh $302.01 ATH on 2024-09-13 on AI-data-platform and Fed-cut optimism. (5–7) From there the thesis met reality: the mortgage recovery kept getting pushed out, hiring slowed, and Experian-Verify competition fears took hold, knocking the stock from its $262.95 52-week high (2025-07-09) to $158.48. The most telling move is #7 — the stock fell ~27% in 2026 even though Q1’26 was a clear beat, because management held rather than raised guidance citing Iran-conflict uncertainty and the negative-momentum tape did the rest. The price move is Fact; the cyclical-versus-structural cause is the central Interpretation the body adjudicates.
1. Executive Summary
Equifax is a data, analytics, and decisioning company built on two genuinely scarce assets: a one-of-three national consumer-credit-bureau position in the United States, and The Work Number — a proprietary payroll-fed database of income and employment records that anchors the highest-quality segment in the entire information-services group. FY25 revenue was $6,074.5M (+6.9%), with three reporting segments of very different quality: Workforce Solutions (43% of revenue, $2,582.3M, a 44.2% operating margin and ~63% of total segment profit), U.S. Information Solutions / USIS (34%, $2,078.5M, 22.9% margin), and International (23%, $1,413.7M, 12.9% and falling). GAAP diluted EPS was $5.32; adjusted EPS was $7.65; FY26 guidance is revenue ~$6.745B and adjusted EPS $8.54 (+11%).
The investment question is not whether Equifax is a good business — Workforce Solutions’ 44% segment margin and the bureau oligopoly settle that — but whether a ~47% drawdown has over-corrected. The stock peaked at $302 in September 2024 priced as a 13–15% secular Workforce compounder; as that growth decelerated to a +5% trough in Q3’25 and the mortgage market sank to multi-decade-low volumes, the market re-rated it from ~25x EV/EBITDA toward ~13x. The unusual feature is that the de-rate occurred into improving fundamentals: revenue rose every year of the drawdown, and Q1-2026 delivered +14% revenue, +13% organic growth, and +22% adjusted EPS.
Three things are simultaneously true. (1) The franchise is real but narrowing — Workforce Solutions is a genuine data-network moat, but Equifax’s own filings concede the verification service has low barriers to entry, and Experian Verify is replicating the model. (2) The cyclical headwinds are severe but recoverable — U.S. mortgage inquiries are down >50% from their 2015–19 average, and there is a latent refi pool of >15M loans above 5% that converts to high-margin revenue the moment rates fall (management sizes a full recovery at +$1.2B revenue and +~$5.75 of incremental adjusted EPS). (3) The cash economics are inflecting — the multi-year, ~$3B EFX Cloud build is substantially complete, capex has fallen from 12.2% to 7.9% of revenue, and true free cash flow rose from a $133M trough (FY22) to ~$1.13B (FY25). Against all of this, the market is pricing perpetual low-single-digit growth. The valuation embeds the bear case; the body that follows adjudicates whether that pessimism is warranted.
2. Business Overview
Equifax (founded 1899; headquartered in Atlanta; fiscal year ends December 31; CIK 0000033185) is organized into three reporting segments whose economics differ sharply. Roughly 77% of revenue is United States. Revenue is overwhelmingly transactional and subscription-based on proprietary data — recurring in the sense of repeated, embedded usage, but volume-sensitive to the credit and mortgage cycles.
Workforce Solutions — the crown jewel (43% of revenue, the highest margin, and essentially the entire quality thesis). FY25 revenue $2,582.3M (+6%) with operating income of $1,141.5M at a 44.2% operating margin — up from 43.3% (FY24) and 41.9% (FY23). On 43% of revenue it produces roughly 63% of the company’s ~$1.80B of total segment operating income. It has two unequal sub-lines:
- Verification Services — $2,179.8M (+8%), the engine. Income- and employment-verification “pulls” monetized through The Work Number, plus criminal-justice, education, and licensure verification, sold to mortgage lenders, consumer-finance lenders, government social-services agencies, and pre-employment screeners.
- Employer Services — $402.5M (−2%), a structurally lower-quality, declining HR-business-process bundle (unemployment-claims management, I-9/onboarding, ACA compliance, tax credits). It fell 12% in FY24 on the wind-down of the federal Employee Retention Credit, and management guides it to decline again in FY26 (the Work Opportunity Tax Credit was not extended).
USIS — U.S. Information Solutions (34% of revenue, a real but cyclical oligopoly). FY25 revenue $2,078.5M (+10%), operating income $475.2M at a 22.9% margin (rising from 21.4%/21.2%). This is one of the three U.S. national consumer credit bureaus. Online Information Solutions ($1,821.4M, +10%) is consumer and commercial credit, mortgage tri-merge credit reports, identity and fraud (Kount), and consumer solutions; Financial Marketing Services ($257.1M, +6%) is credit-marketing and prescreen. The 2025 growth was pricing-led and partly offset by lower inquiry volumes — pricing power masking a cyclical volume headwind.
International (23% of revenue, the structurally weak leg). FY25 revenue $1,413.7M (+4% reported / +6% local-currency), operating income $182.5M at a 12.9% margin and falling. Latin America ($403.4M, lifted by the 2023 Boa Vista acquisition in Brazil), Europe ($396.7M), Asia-Pacific ($342.3M), and Canada ($271.3M). These mirror USIS products but are sub-scale versus Experian, FX-exposed (Argentina, Brazil), and margin-dilutive.
The five-year GAAP operating-margin compression (23.1% FY21 → 18.0% FY25) is not segment deterioration — both Workforce Solutions and USIS margins rose over the window — but the amortization tail of the EFX Cloud rebuild plus International mix. Verdict: a high-quality information-services company whose value is heavily concentrated in one exceptional segment (Workforce Solutions), supported by a solid oligopoly second leg (USIS) and a weak third leg (International). To understand Equifax is to understand The Work Number.
3. Industry Dynamics
Equifax operates across two distinct industry structures — both attractive, both facing identifiable supply-side and regulatory pressure.
(A) The credit-bureau oligopoly (USIS / International). The U.S. consumer-credit data layer is a tight, durable three-firm oligopoly — Experian, Equifax, TransUnion. Its defensibility is a textbook Greenwald economies-of-scale + regulatory-barrier moat: most U.S. lenders voluntarily furnish credit data to all three bureaus, creating a self-reinforcing data cooperative no entrant can replicate (you cannot will a national credit file into existence), and Fair Credit Reporting Act (FCRA) compliance is itself a real barrier to entry. Every conforming mortgage requires a tri-merge report pulling all three bureaus, making each bureau a non-substitutable input. Equifax layers on proprietary adjacencies: it manages the NCTUE telecom/utility exchange and owns Kount (digital identity/fraud).
The VantageScore angle is a structural tailwind — the inverse of the FICO bear case. Equifax is one of three equal owners of the VantageScore joint venture. The FHFA’s July-2025 approval of VantageScore 4.0 for conforming mortgages — which ended Fair Isaac’s de-jure score monopoly — helps the bureaus two ways: any VantageScore share gain captures score-layer economics Fair Isaac previously monopolized (VantageScore priced at ~$1 versus FICO’s mortgage royalty journey from $4.95 toward $10), and the tri-merge data-pull requirement was retained, protecting each bureau’s underlying data revenue regardless of which score wins. The bureaus own both the uncontested data layer and the rival score — they are the structural winners of the scoring war. The magnitude is modest and undisclosed near-term and is not in Equifax’s guidance, but it is directionally positive, not a threat.
(B) The verification industry (Workforce Solutions). This is the higher-return, more contested structure. The Work Number’s payroll-fed database is a genuine proprietary asset, but — strikingly — Equifax’s own 10-K Competition section describes Verification Services as “highly competitive with low barriers to entry,” listing in-house employer verification, lenders going direct to source, and “numerous online and offline firms.” The defensibility lives in the contributor base, not the service.
Regulatory landscape. The governing regime is the FCRA, supervised by the CFPB (plus the FTC and state attorneys general), with a private right of action and fee-shifting that makes the sector a class-action magnet. State privacy laws and a rising tide of data and AI regulation add cost. This regulation is double-edged: it entrenches incumbents (raising entry barriers) while capping conduct and inviting enforcement. Two active overhangs sit on the crown jewel — a May-2024 antitrust class action (E.D. Pa.) over the verification business, and three CFPB civil investigative demands (2023–2024) probing The Work Number’s data accuracy and dispute handling. The 2017 breach legacy still appears in the current risk factors.
Capital-cycle (Marathon) lens. Data oligopolies are exactly the durable high-return niches that resist new capital because the cooperative cannot be purchased — but the supply-side response is visible. Experian is replicating The Work Number’s playbook with Experian Verify; fintechs (Plaid, Argyle, Truework) attack with consumer-permissioned “instant” payroll connections; and payroll processors (ADP, Paychex) sit on the same data and could disintermediate. The very 44% Workforce margin that signals a moat is the return that attracts this capital — classic mean-reversion pressure at the service margin, even as the data layer holds.
Verdict: a structurally good industry — a regulated bureau oligopoly plus a proprietary verification data cooperative, recurring transactional revenue, high data-exclusivity barriers — but with two real structural pressures (rising verification competition; intensifying CFPB/antitrust/privacy scrutiny) and pronounced U.S.-mortgage cyclicality. A good industry whose best segment is maturing.
4. Competitive Position
Workforce Solutions / The Work Number is the entire moat thesis — and it is real. At 12/31/25, The Work Number held ~209M active and 813M total employment records, sourced from “over 4 million organizations.” The trend is the proof of the network mechanism: contributor organizations went from “over two million” (FY22) to “over three million” (FY23) to “over four million” (FY24–25), and active records climbed to 209M (+11% in the last year alone; total records 600M FY22 → 813M FY25). The structure is a twin-sided data network with Greenwald demand-captivity plus data-scale economics: employers and payroll providers contribute current payroll feeds for free (they get relief from the burden of fielding verification requests), and Equifax monetizes per-transaction pulls by lenders, government agencies, and screeners. More contributors → higher hit rate → more verifier demand → more incentive for payroll partners to integrate → more contributors. Equifax notes it has “not experienced significant turnover in employer contributors.” The 44% segment operating margin — and a segment ROIC far above the cost of capital — is exactly what a genuine franchise produces, and it is the justification for Equifax’s entire premium.
The skeptical pressure-test — durable but narrowing. Three caveats keep this from being unassailable. (1) The defensibility is the contributor cooperative, and Experian is actively replicating it via the identical payroll-partner model (Experian Verify), while Truework/Argyle/Plaid attack with consumer-permissioned data and lenders increasingly run an “instant-then-fallback” verification waterfall that can route around The Work Number. (2) Equifax’s own 10-K concedes the verification service has “low barriers to entry” — the moat is the data, not the product. (3) The crown jewel carries a regulatory/litigation overhang (the E.D. Pa. antitrust class action and three CFPB CIDs) that both signals the high rents drawing scrutiny and could constrain pricing. Pricing power has been demonstrated (Verification +8% despite soft volumes) but is increasingly contested.
USIS — a real scale/regulatory moat. As one of three national bureaus feeding every tri-merge mortgage, USIS holds a structural, non-substitutable position with a near-zero-incremental-cost data product, and the VantageScore tailwind is a modest positive rather than a threat.
On the “8% ROIC doesn’t prove a moat” objection. Blended GAAP ROIC of ~8.2% and ROE of ~10.2% (FY25) do not disprove the franchise — they reflect ~$6.7B of goodwill from a decade of acquisitions (Kount, Appriss Insights, Boa Vista) plus the EFX Cloud capex bulge sitting on the balance sheet, not poor unit economics. The correct test is segment economics — Workforce 44% / USIS 23% operating margins on near-zero-incremental-cost data products — which are unambiguously franchise-grade.
Verdict: a durable-but-narrowing competitive advantage. Workforce Solutions / The Work Number is a genuine wide-moat data asset (the whole quality story and the premium justification); USIS is a real bureau-oligopoly scale/regulatory moat with a modest VantageScore tailwind. But the lead is contested, not unassailable — Equifax’s own filings admit the service layer has low barriers, Experian is replicating the contributor model, and CFPB/antitrust scrutiny presses the franchise. The central investment debate is whether Workforce Solutions’ growth deceleration and the blended-margin compression are cyclical (mortgage recession + hiring slowdown + cloud-spend tail) or the first signs of structural maturation of the moat.
5. Growth History and Forward Opportunities
The historical record — the secular-compounder story that worked, then stalled. Revenue compounded from $4,127.5M (FY20) to $6,074.5M (FY25), an ~8% five-year CAGR, but the path masks two regimes. The 2021–22 boom was driven by a mortgage super-cycle and the early ramp of The Work Number: Workforce revenue jumped +14% in FY22 (Verification +16%), and the market extrapolated a permanent 13–15% compounder. The hangover followed: as mortgage collapsed in 2022–23, Workforce revenue went flat in FY23 (−0.4%) and Verification actually declined 1% — the first crack in the narrative. Workforce then recovered to +5% (FY24) and +6% (FY25), with Verification back to +10% / +8%.
The quarterly cadence inside FY25 is the crux of the price action. Workforce revenue grew +8% in Q2’25, decelerated to +5% in Q3’25 (the trough), then re-accelerated to +9% in Q4’25 and +10%+ in Q1’26, with Verification specifically hitting +14% in both Q4’25 and Q1’26. Equifax exited the drawdown growing faster than it printed mid-2025 — but the Q3’25 +5% print, landing against a 13–15% framework, was the moment the secular thesis was repriced.
Composition matters. Inside Verification, four diversified verticals are doing the work: government (~$800M run-rate, growing mid-double-digits on social-services verification), consumer lending (auto/card/personal-loans, running +19–20% — though management explicitly flags this is not a sustainable run-rate), talent / pre-employment (hiring-cyclical, below plan in Q3’25 as BLS hiring ran negative), and mortgage. The Work Number’s data records keep compounding (~211M active / 120M current records, +11% / +9% as of Q1’26) against a ~250M income-producing-American addressable base, with Equifax now expanding beyond payroll processors into HR-software partners. USIS (+10% in both FY24 and FY25, mortgage-price-driven) and International (+10% FY24 → +6% local-currency FY25) were the offsets that kept the consolidated number respectable while Workforce stalled.
The mortgage swing factor. U.S. mortgage is ~20–22% of total revenue and high-margin, and it is in a multi-decade volume depression: hard mortgage inquiries are down >50% versus the 2015–19 average. Equifax has bridged the volume hole almost entirely with price — USIS mortgage revenue grew +20% → +26% → +33% → +60% across Q2’25–Q1’26 against falling volumes. A large part of that is the FICO score price pass-through (FICO raised the mortgage-score price toward $10 for 2026), which flows through Equifax’s P&L at zero margin (~6% of total revenue in 2026, roughly doubling from ~3%, mechanically diluting reported EBITDA margin ~200bps). Equifax’s own credit-file price increase is “modest” — management was emphatic it is “100 miles away from” the FICO doubling — and ex-FICO, USIS mortgage still grew +24% in Q1’26 on genuine share gains. This is the single biggest cyclical option in the model: management sizes a full recovery to 2015–19 volumes at +$1.2B revenue, >$950M EBITDA, and >$5.75 of incremental adjusted EPS, against a refi pool of >15M mortgages above a 5% rate.
Forward opportunities (treated as upside, not baked in). (1) Government / “One Big Beautiful Bill.” Equifax’s government vertical (~$800M, ~$5B TAM) is positioned to inflect on the bill signed July 2025 — Medicaid redetermination frequency, SNAP error-rate penalties, and work requirements verified through The Work Number — weighted to 2H’26 and 2027+. (2) VantageScore mortgage conversion — full adoption is worth ~+$160M EBITDA / ~+$1 adjusted EPS, explicitly not in guidance (but a hard sell — VantageScore holds ~5% share after 20 years in auto/card). (3) EFX.AI / new-product velocity — the Vitality Index (revenue from recently-launched products) hit 17% in Q1’26 versus a 10% goal, with 100% of new models built on EFX.AI. (4) Cloud-complete margin and FCF inflection (see ).
The medium-term framework (“rule of ~50”): 7–10% organic revenue (USIS 6–8 / Workforce 13–15 / International 7–9), ~50bps/yr EBITDA-margin expansion, and ≥95% FCF conversion. Management’s June-2025 Investor Day framed 2030 scenarios: a base case (~2–3% mortgage market) of ~$9.6B revenue and ~$15 adjusted EPS, and a mortgage-recovery case of ~$10.8B and ~$19 adjusted EPS. Verdict: the growth is real but its quality is currently in question. Workforce is structurally advantaged (proprietary data) but FY26 Workforce/Verification is guided below the 13–15% framework, and a meaningful slice of recent “growth” is zero-margin FICO pass-through and an unsustainable consumer-lending run-rate. This is high-quality data underlying a temporarily lower-quality growth print; the bull/bear hinges on whether the framework is reattainable in 2027.
6. Financial Quality
The headline arc is a high-quality franchise whose reported returns deteriorated through a self-inflicted, partly-cyclical trough — and which is now inflecting out of it. Revenue compounded from $4,923.9M (FY21) to $6,074.5M (FY25), but GAAP operating margin fell: 23.1% → 20.6% → 17.7% → 18.3% → 18.0%. That is the single most important number in this section: a credit-bureau oligopolist with 56% gross margins should not see operating margin compress 500bps while revenue grows 23%. The bridge is threefold: (i) the 2021–23 rate shock gutted high-incremental-margin online query revenue (the most operationally-levered revenue Equifax has — incremental operating margin went negative in FY22–23 versus +58% in FY21); (ii) the EFX Cloud build layered in opex and a rising wall of D&A; and (iii) dilutive M&A brought lower-margin, integration-heavy revenue. D&A on the income statement climbed every year — $489.6M → $568.6M → $610.8M → $669.8M → $719.5M (FY21–25).
Quality-of-earnings — the capitalized-software question. The EFX Cloud build was financed by aggressively capitalizing internal-use software: gross “capitalized internal-use software and system costs” stand at $3,098.2M (FY25) versus $2,817.5M (FY24) — $280.7M of fresh additions in a single year, roughly 85% of total gross PP&E. This is the mechanism a skeptic should watch: development cost that bypasses the income statement (capitalized, not expensed) flatters both operating margin and “adjusted EBITDA,” which then adds back $719.5M of D&A — i.e., adjusted EBITDA excludes precisely the line where the deferred development cost reappears. The mitigant is that true free cash flow now validates the cash generation. Computing true FCF = CFO − total cash capex:
| FY | CFO ($M) | Cash capex ($M) | True FCF ($M) | True FCF / GAAP NI |
|---|---|---|---|---|
| 2021 | 1,334.8 | 464.1 | 870.7 | 1.17x |
| 2022 | 757.1 | 624.5 | 132.6 | 0.19x |
| 2023 | 1,116.8 | 601.3 | 515.5 | 0.95x |
| 2024 | 1,324.5 | 511.5 | 813.0 | 1.35x |
| 2025 | 1,615.7 | 481.4 | 1,134.3 | 1.72x |
FY22 was a genuine trough ($132.6M) — peak capex (12.2% of revenue) colliding with a $625.6M working-capital drag. By FY25, capex has fallen to 7.9% of revenue and true FCF reaches $1,134.3M, or 172% of GAAP net income, closely matching the company’s own ~$1.0–1.1B reported FCF at “120% cash conversion.” The “FCF inflection as cloud capex rolls off” thesis is real and now visible, not just narrative: capex fell 12.2% → 11.4% → 9.0% → 7.9% of revenue, and management guides it lower with the cloud transformation “substantially complete.” The deferred development cost is now being paid (rising software amortization) while cash capex falls — exactly the order one wants.
Adjusted versus GAAP — defensible, with one flag. Equifax reports adjusted EPS of $7.65 (FY25) versus GAAP diluted $5.32 — a +44% uplift — and FY26 guidance of $8.54 on revenue of $6.745B. The bulk of the bridge is acquisition-intangible amortization (~$250M pretax, ~$1.60/share after tax) — a defensible add-back for a serial acquirer of data assets. The softer item is restructuring ($49.9M FY25, $48.0M FY24), recurring for five-plus consecutive years and tied to “completing the cloud transformation,” which strains the one-time label. Net assessment: the adjusted number is high but mostly clean; the recurring restructuring is the one item a committee should haircut, and the truer cash anchor is the ~$1.13B of FCF, not the headline EPS.
Returns. ROIC of ~8.2% (FY25, down from 10.9% in FY21) sits roughly at the cost of capital; ROE is ~10.2% (versus 15.8% FY21). Both are depressed by goodwill and purchased intangibles (negative tangible book) and by the mortgage-cycle hit, not by weak unit economics. Verdict: economics did not improve with scale over 2021–25 — they compressed to value-neutral — but the deterioration was driven by a once-in-a-decade rate shock plus a finite cloud build, and the operating leverage is real on the recovery (management guides +75bps margin expansion ex-FICO in FY26, above its 50bps long-term framework). The quality-of-earnings is clean-enough: the capitalized-software concern is genuine but offset by validated FCF, and the adjustments are mostly amortization rather than fiction.
7. Capital Allocation
M&A is the value-defining call, and the verdict on price is mixed-to-poor. In 2021 Equifax spent ~$2.94B on acquisitions — Kount $640M (USIS fraud/identity), Appriss Insights $1.825B (Workforce government and incarceration data), plus tuck-ins — followed by Boa Vista Serviços ~$580M (2023, Brazil) and smaller deals (Vault Verify, 2025). These were strategically coherent — Appriss deepens the Workforce data moat — but they were transacted into a cyclical peak, and the receipt is the ~$6.7B goodwill pile and the slide in ROIC from 10.9% to ~8%. The price paid is not yet earning its cost of capital; whether it ever does depends on Workforce query volumes normalizing. Management has since pivoted to bolt-on tuck-ins only, with ~$1.5B/yr of stated capacity for M&A-plus-returns.
Shareholder returns ramped — late, and with a short track record. Buybacks were $927.5M in FY25 (4.0M shares, including $500M in Q4 on a weak stock) versus essentially $0 in FY23–FY24. A new $3B authorization was approved in April 2025; Q1’26 added $260M. Shares outstanding fell from 124.0M to 120.4M. The dividend, frozen for years at $0.39/quarter, was lifted to $0.50 (April 2025) and then +12% to $0.56/quarter (March 2026) — a ~35% GAAP payout (~26% of adjusted EPS). The reason buybacks were suppressed from 2017 to 2024 is the 2017-breach cash drain — a cumulative ~$1.4B+ of pretax charges (including the $380.5M Consumer Restitution Fund) on top of cloud capex and M&A. That tail is now small (a $15M CFPB item in Q1’25; a $13.5M UK FCA penalty in 2023), which is precisely why capital return could finally ramp. The ramp is sensible (returning genuine excess FCF, opportunistically on a weak stock), but Equifax has essentially no multi-year buyback record at scale, so price discipline is unproven.
Balance sheet. Total debt $5,114.2M (FY25): commercial paper $762M plus senior notes laddered 2026–2037, at a weighted-average cost of 4.3%, weighted-average life 3.38 years, 85% fixed-rate. Net debt is ~$4.9B (~2.7x EBITDA); current maturities $1,038M. The covenant max leverage is 3.5x (4.25x for material M&A); the company is compliant and investment-grade (BBB/Baa). Leverage is comfortable and refinancing risk is modest — but the negative tangible book and ~2.7x leverage leave no balance-sheet cushion for a catastrophic event.
Incentives and insiders — the alignment yellow flag. The proxy (filed March 2026) reveals no return-on-capital metric anywhere in the incentive structure. The annual plan keys on operating revenue plus adjusted EPS (CEO 81.25% adjusted-EPS / 18.75% revenue); the long-term plan on relative TSR plus absolute adjusted EBITDA. “Return on invested capital” appears only in non-GAAP boilerplate, never as a metric. A revenue/EPS/EBITDA-growth scorecard rewards exactly the empire-building that produced the ~8% ROIC — there is no governor on capital efficiency. CEO Mark Begor’s FY25 total comp rose to $23.4M (from $14.8M) on a higher LTI target. Insider behavior reinforces the caution: across the full 18-month Form 4 corpus (94 filings, 190 transaction lines), there was exactly one open-market purchase — a director’s ~$465K buy (Cecilia Mao, February 2026) — against 54 sales; CEO Begor made zero buys and ran a routine same-day exercise-and-sell pattern into prices from $256 down to $171.
Verdict: mixed. Disciplined breach-paydown and delevering, and a sensible — if late and unproven — capital-return ramp now that FCF has inflected. But the value-defining 2021 M&A was richly priced into a cyclical top (the goodwill and sub-WACC ROIC are the bill), the comp design lacks any return-on-capital governor, and insiders are net sellers. Competent stewardship today, weak alignment on the metric that matters.
8. Changes and Headwinds — Last Two Years
The dominant change is the guidance-and-credibility arc, not a single corporate event. The pivotal print was Q2’25 (2025-07-22): despite an H1 beat, management held constant-FX full-year guidance flat, cut the FY Workforce revenue outlook to ~+5% from ~+7%, layered in government “near-term headwinds,” and raised the corporate-expense line to ~$590M on rising consumer-litigation costs. The “balanced/prudent” framing did not land — the stock fell hard from its 52-week high of $262.95 (2025-07-09) within weeks. Q3’25 (2025-10-21) then raised guidance (a catch-up), and Q4’25 (2026-02-04) set FY26 at ~$6.7B revenue / $8.50 adjusted EPS (+11%) / >$1B FCF. Then Q1’26 (2026-04-21) delivered a clean beat (revenue +14%, adjusted EPS $1.86, +22%) but management declined to raise full-year guidance (an FX-only nudge to $8.54), citing Iran-conflict uncertainty — stating outright, “absent the uncertainty… we would have raised.” That sequence — beat-but-hold, twice — is the proximate driver of the trailing-12-month de-rating.
Capital-allocation ramp (a genuine positive change). With the cloud build winding down, Equifax pivoted to returning cash: the $3B buyback authorization (April 2025), $1.2B returned in FY25 (6x FY24), and two dividend increases. Leadership/governance: CEO Mark Begor (since 2018, hired to clean up post-breach) remains in place; a new USIS President (David Smith) joined in 2026 alongside refreshed International leadership — orderly, not disruptive, though succession is an open question given Begor’s tenure.
Regulatory and legacy items. The 2017-breach legacy has wound down to a tail (the last material item was the $13.5M UK FCA penalty in 2023). Equifax remains FCRA-regulated by the CFPB — a standing overhang for all bureaus and a swing factor under shifting administrations. The FHFA/VantageScore approval (July 2025) is a net-positive change that opened the conversion option. Finally, the AI-disintermediation fear crystallized in the early-2026 selloff — Begor: “we’ve clearly been swept into a neighborhood we don’t think we live in” — prompting a sustained “data-as-moat” defense (~90% of revenue from proprietary data not on the open web). Verdict: on balance these changes strengthen the long-term thesis (capital return, cloud-complete FCF, VantageScore/government optionality) but weaken near-term credibility (twice beating and refusing to raise, Workforce below framework, rising litigation costs).
9. Risk Analysis
| # | Risk | Likelihood | Impact | Evidence basis |
|---|---|---|---|---|
| 1 | Mortgage-cycle / rate-driven volume | High | Med–High | U.S. mortgage in both Workforce & USIS; FY26 originations guided down LSD; FICO royalty ~6% of revenue at $0 margin. Cyclical, recoverable (refi pool >15M loans >5%). |
| 2 | Workforce verification competition / maturation | Medium | High | Experian Verify replicating contributor model; 10-K admits Verification “low barriers to entry”; consumer-permissioned rails. The crown-jewel risk. |
| 3 | Data-security breach (catastrophic tail) | Low–Med | Catastrophic | 2017-breach precedent (lost certifications, paused customers, impairment). The company is its data; negative tangible book = no asset cushion. |
| 4 | Regulatory — FCRA / CFPB / state privacy | Med–High | Med–High | CFPB CIDs on The Work Number accuracy/disputes (2023–24); FCRA private right of action with fee-shifting; tightening state privacy/AI law. |
| 5 | Antitrust / litigation overhang | Medium | Medium | 2024 antitrust class action (E.D. Pa.) targeting the verification business; ongoing FCRA litigation magnet. |
| 6 | Leverage / interest-rate refinancing | Low–Med | Medium | ~2.7x net-debt/EBITDA, $5.1B debt, negative tangible book. Manageable at IG but limits flexibility; refi at higher rates a drag. |
| 7 | Government-contract concentration | Medium | Medium | Government revenue growing mid-double-digits but SSA a tough comp; WOTC expiry pressuring Employer Services; OB3 pipeline timing (2027+) uncertain. |
| 8 | Cyclicality — hiring / talent-screening | Medium | Low–Med | Talent Solutions tied to hiring; Employer Services declining (WOTC, ERC/I-9 wind-down). Macro-sensitive but smaller. |
| 9 | M&A integration / capital misallocation | Medium | Medium | ~$6.7B acquisition goodwill (Kount, Appriss, Boa Vista); ROIC ~8% partly a goodwill artifact; bolt-on cadence risks overpayment. |
| 10 | AI / data-disruption of verification | Low–Med | Medium | Management argues payroll data is “not on the web,” accessible only via EFX.AI. Plausible, but agentic-AI verification is an emerging unknown. |
| 11 | Key-person (CEO Begor) | Low | Low–Med | Turnaround/cloud architect; succession not the central risk but unannounced given tenure. |
The two risks that define the thesis are #1 (mortgage cyclicality — the recoverable swing factor and the embedded option) and #2 (Workforce competition/maturation — the structural risk to the crown jewel). Risk #3 (a catastrophic breach) is low-probability but, for a company that is its data and carries negative tangible book, is the genuine total-loss tail — and the 2017 precedent means it cannot be dismissed.
10. Valuation Discussion (Embedded Expectations)
The setup in one line: the highest-quality bureau franchise in the group, trading at the cheapest multiple of its own decade and the cheapest of its peer cohort, while its fundamentals are accelerating. At the $158.48 reference, ~120.5M diluted shares put market capitalization at ~$19.1B. Adding $5.09B of debt and subtracting $0.18B cash and $0.13B minority interest gives an enterprise value of ~$24.1B. Against FY25 EBITDA of $1,822M, that is ~13.2x EV/EBITDA. GAAP P/E on TTM EPS of $5.68 is ~27.9x — but GAAP understates Equifax badly because of cloud-transformation and acquisition amortization. On management’s FY26 adjusted-EPS guide of $8.54, the forward multiple is ~18.6x. True free cash flow of ~$1.13B puts Equifax at ~16.8x P/FCF, a ~5.9% FCF yield, with EV/Sales at ~4.0x.
Own-history context is the headline. Own-history valuation data place Equifax at the 9.8th percentile of its own ~decade composite — P/E at the 19th percentile, P/B (4.22x) at the 9.6th, and P/S (3.10x) at the 0.66th percentile, an extreme. EV/EBITDA history confirms a violent de-rate: it ran 24x (FY20), 25x (FY21), 18x (FY22), 23x (FY23), 21x (FY24) — and now sits at ~13x, roughly a 40% compression from the 2021 peak and below even the FY22 mortgage-crash trough. (Price-to-tangible-book is negative every year — ~$6.7B goodwill, negative tangible common equity — so reported P/B is the only usable balance-sheet multiple, and the negative tangible book is itself part of the bear case.)
The crucial fact: the de-rating is happening into improving numbers, not deteriorating ones. Q1-2026 delivered revenue $1.649B (+14%), organic constant-currency growth of +13% (200bps above the company’s framework), adjusted EPS $1.86 (+22%), ex-FICO EBITDA margin +80bps, and a record 17% Vitality Index. U.S. mortgage revenue was +38%. Management stated it “would have raised” full-year guidance absent geopolitical uncertainty, and instead held the constant-currency FY26 guide (revenue ~$6.745B, organic ex-FICO +7–9%, EBITDA margin ex-FICO +75bps, adjusted EPS $8.54, FCF >$1.0B at ≥100% conversion). So the price has fallen ~38% over twelve months while the income statement compounded.
Comp table — Equifax is the cheap outlier of the high-quality info-services cohort (multiples approximate, same-day basis):
| Company | EV/EBITDA (fwd) | P/E (fwd adj) | P/FCF | EV/Sales | Organic growth | EBITDA margin | Note |
|---|---|---|---|---|---|---|---|
| Equifax (EFX) | ~13x | ~18.6x | ~16.8x | ~4.0x | +7–9% | ~30–31% | Cheap outlier; mortgage-cyclical; levered 2.7x |
| S&P Global (SPGI) | ~20–22x | ~26–28x | ~25x | ~9–10x | ~6–8% | ~50%+ | Higher returns, net-cash, ratings duopoly |
| Moody’s (MCO) | ~22–25x | ~30–33x | ~28x | ~11x | ~7–10% | ~48% | Ratings duopoly, premium quality |
| Verisk (VRSK) | ~22–25x | ~30x | ~28x | ~13x | ~7–9% | ~54% | Insurance data, subscription, asset-light |
| Fair Isaac (FICO) | ~30x+ | ~45x+ | ~40x+ | ~25x | ~10–15% | ~55% | Score franchise; richest in group |
| TransUnion (TRU) | ~12–14x | ~17–20x | ~16x | ~4–5x | ~5–9% | ~37% | Closest bureau peer; also de-rated |
| Experian (EXPN.L) | ~16–18x | ~23–26x | ~22x | ~6x | ~6–8% | ~37% | Bureau + the Verify competitive threat |
Equifax and TransUnion are the two de-rated bureaus, dragged together by the same forces — mortgage cyclicality, verification competition, and leverage. Why EFX trades ~7–10 EV/EBITDA turns below SPGI/MCO/VRSK is partly deserved and partly excessive: (1) lower GAAP returns (ROIC ~8% vs mid-teens-to-20s), reflecting goodwill and the cloud bulge rather than poor unit economics (Workforce earns 44% margins); (2) higher mortgage cyclicality plus the zero-margin FICO pass-through optically dragging margin; (3) leverage and negative tangible book versus the net-cash premium names; (4) the 2017-breach discount; (5) the Experian-Verify overhang on the highest-margin segment. The deserved discount is real — but a ~10-turn gap to Moody’s over-discounts a franchise whose crown-jewel segment grows double digits at >40% margins.
Embedded-expectations / reverse-DCF. At ~$24.1B EV / ~13x EBITDA / ~18.6x forward adjusted EPS, the market is underwriting roughly low-single-digit perpetual growth with no multiple recovery — it treats Workforce’s deceleration as structural, mortgage as depressed indefinitely, and the 50bps/yr margin framework as broken. That is sharply below both management’s 7–10% organic framework and the Q1’26 +13% organic run-rate.
Scenarios (FY26 adjusted EPS of $8.54 grown to FY28, applied to an exit P/E; corroborated by a three-year-out EV/EBITDA build):
| Scenario | Key assumptions | FY28E adj EPS | Exit P/E | Implied value | vs spot |
|---|---|---|---|---|---|
| Bear | Workforce decelerates to MSD on Verify share loss; mortgage stays depressed; margin stalls; stays cheap | ~$9.24 | ~15x | ~$139 | −13% |
| Base | 7–9% organic per framework; mortgage stabilizes/modest recovery; +50–75bps margin; partial re-rate | ~$10.33 | ~19x | ~$196 | +24% |
| Bull | Mortgage refi wave (rates fall) + Workforce reaccel + VantageScore + cloud-complete FCF; re-rate to peers | ~$11.29 | ~23x | ~$260 | +64% |
The asymmetry is positive: the bear case sits roughly at spot, while the base and bull are materially higher — the price embeds the bear. The single largest sensitivity is the multiple itself: a re-rate from ~13x to a peer-ish 16–18x EV/EBITDA is ~25–40% before any earnings growth. The largest fundamental swing is U.S. mortgage — a latent refi pool of >15M loans above 5% converts to high-margin revenue the moment rates fall. No price target; the figures above are scenario illustrations, not a target.
11. Variant Perception
Consensus. The market has re-cast Equifax from “secular data compounder” (the $300 stock of 2024) to “broken cyclical”: Workforce’s growth is maturing as The Work Number nears penetration, Experian Verify and consumer-permissioned fintechs are commoditizing verification, mortgage is structurally depressed, leverage and negative tangible book cap the quality rating, and the 2017-breach tail never fully goes away. In this view, the de-rate from ~25x to ~13x is a permanent re-rating to the company’s true (lower) quality. The factor tape agrees: negative momentum, negative Sharpe across every horizon, traded as a high-beta mortgage/value cyclical.
Strongest bull case. The deceleration is cyclical, not structural. Q1’26 organic growth was +13% with Verification +14% — not the profile of a maturing asset. Three catalysts converge: (1) mortgage refi optionality — a >15M-loan above-5%-rate pool that reprices the moment the Fed cuts, lifting the highest-revenue-per-transaction vertical in both Workforce and USIS; (2) the EFX Cloud transformation is “substantially complete” (~90% of revenue on the new cloud), ending the capex bulge and inflecting FCF toward >$1.2–1.3B — a self-funded ~$1.5B/yr capital-return engine; (3) VantageScore — Equifax co-owns the JV, the mortgage price was cut to ~$1 to force conversion, and full conversion is worth ~+$1 of adjusted EPS not in guidance. Layer the cheapest multiple in a decade and the cheapest of the quality cohort, and this is a quality compounder on sale — the classic post-darling de-rate that mean-reverts when the cyclical fog lifts.
Strongest bear case. Workforce is structurally maturing. The Work Number’s active-record growth is decelerating in percentage terms, the company’s own 10-K calls Verification “highly competitive with low barriers to entry,” and Experian Verify is replicating the identical payroll-contributor playbook while consumer-permissioned rails attack from below. The 44%-margin crown jewel — the entire premium justification — is the asset under attack. Mortgage may stay depressed for years (originations guided down in 2026). Leverage (~2.7x) and negative tangible book leave no cushion, and the 2017-breach precedent is a live reminder of catastrophic-loss tail risk for a data company that is its data. CFPB CIDs and a 2024 antitrust class action target the franchise directly. On the tape it is a high-beta falling knife with no floor — a value trap until proven otherwise.
The assumptions that matter most, with falsification evidence:
- Workforce Verification growth is cyclical, not structural. Bull falsified if Verification organic decelerates toward mid-single-digits over 2–3 quarters with evidence of Experian-Verify hit-rate parity. Bear falsified if Verification holds low-double-digits (it was +14% in Q1’26) while mortgage stays weak — proving the diversified drivers, not just mortgage.
- Mortgage is cyclical optionality, not a permanent drag. Bull falsified if rates stay high and the refi pool never converts through 2027. Bear falsified if a rate-cut cycle triggers the >15M-loan refi wave.
- The FCF inflection is real. Bull falsified if capex stays elevated post-“cloud-complete” and conversion lags 100%. Bear falsified if FCF clears >$1.2B in 2026 at >100% conversion.
- The multiple re-rates. Bull falsified if EFX stays at ~13x while the cohort holds 20x+. Bear falsified if it closes even half the gap to TransUnion-plus.
- No catastrophic data/regulatory event — resolved either way by a breach, an adverse CFPB/antitrust action, or clean resolution of the CIDs and antitrust suit.
Factor-positioning read as evidence. The factor model shows Equifax as a crowded value / abandoned-former-growth-darling: negative Momentum (−0.33), negative Sharpe at every horizon (y1 −1.07), positive Value (+0.23) and Real-Estate/mortgage (+0.52) loadings, and a high 1.40 beta. The negative-momentum, trough-sentiment signature is the strongest evidence that consensus may be offsides — the stock is priced as a cyclical at the bottom of its sentiment cycle, exactly where a quality franchise gets mispriced. The caveat is the same data: a falling-knife tape with no momentum tailwind means there is no technical floor; only a fundamental catalyst reverses it.
12. Fact vs. Interpretation
| Topic | Fact (filings / data) | Interpretation (analyst judgment) |
|---|---|---|
| Workforce Solutions economics | FY25 revenue $2,582.3M, 44.2% operating margin, ~63% of segment profit on 43% of revenue. | A genuine wide-moat data network — but contested, not unassailable; the durability is the central debate. |
| Consolidated returns | ROIC ~8.2%, ROE ~10.2% (FY25); goodwill ~$6.7B; negative tangible book. | Returns reflect richly-priced 2021 M&A + cloud bulge, not poor unit economics; segment economics prove the moat. |
| Margin compression | GAAP operating margin 23.1% (FY21) → 18.0% (FY25), while revenue grew 23%. | Cloud-amortization tail + mortgage-cycle + International mix — recoverable operating leverage, not deterioration. |
| Free cash flow | True FCF $132.6M (FY22) → $1,134.3M (FY25); capex 12.2% → 7.9% of revenue. | The cloud-capex roll-off / FCF-inflection thesis is real and now visible in the numbers. |
| Mortgage | ~20–22% of revenue; inquiries down >50% vs 2015–19; bridged with price; refi pool >15M loans >5%. | The biggest cyclical swing factor and the embedded option; a recovery is upside not in the base price. |
| Adjusted EPS | FY25 adjusted $7.65 vs GAAP $5.32; FY26 guide $8.54; restructuring recurring 5+ years. | Mostly clean (amortization), but haircut the recurring restructuring; anchor on FCF. |
| Valuation | ~13x EV/EBITDA, ~18.6x fwd adj P/E; own-history composite 9.8th percentile; ~47% off ATH. | The price embeds the bear case (~$139); base/bull materially higher — positive asymmetry, no floor. |
| Insiders | One open-market buy (~$465K) vs 54 sells over 18 months; CEO zero buys through the drawdown. | No insider conviction — a caution flag against the cheap-and-accelerating bull narrative. |
13. Open Questions
- Is the Q4’25/Q1’26 Verification re-acceleration to +14% durable, or flattered by FICO pass-through, government timing, and an unsustainable consumer-lending run-rate? This single question decides the cyclical-vs-structural debate.
- Where does Experian Verify’s hit rate actually sit versus The Work Number today? The competitive threat is asserted on both sides but unquantified from the outside.
- Does the One Big Beautiful Bill government revenue land at scale in 2H’26/2027, or slip again? Management’s fastest-growth claim rests on it.
- What is the true normalized (mid-cycle) mortgage contribution, and how much of the >$5.75 of “recovery EPS” is realistic versus a top-of-cycle artifact?
- CEO succession — Begor has run the post-breach rebuild since 2018; there is no announced plan.
- Outcome of the CFPB CIDs and the E.D. Pa. antitrust suit — either could constrain Workforce pricing or impose cost.
14. What Must Be True
For the bull case (the de-rate is a mispricing):
- Workforce/Verification organic growth must hold low-double-digits as the diversified government, consumer-lending, and talent verticals offset weak mortgage — falsification test: two-to-three consecutive quarters of Verification organic decelerating toward mid-single-digits, with evidence of Experian-Verify parity, breaks it.
- Free cash flow must clear >$1.2B at >100% conversion in FY26 as cloud capex rolls off — falsification test: capex stays >9% of revenue and conversion lags 100%.
- The multiple must at least partially re-rate off ~13x EV/EBITDA — falsification test: EFX stays at ~13x while the cohort holds 20x+ for a full year (the discount is permanent and deserved).
For the bear case (it is a value trap):
- Workforce must prove structurally maturing — penetration peaking, Experian Verify taking share, pricing capped by CFPB scrutiny — falsification test: Verification sustains low-double-digit organic growth at stable margins through a weak mortgage and hiring market.
- Mortgage must stay permanently depressed through the next rate-cut cycle — falsification test: a Fed easing cycle converts the >15M-loan refi pool into rising high-margin inquiry/verification revenue.
- A catastrophic data or regulatory event must materialize (or the leverage/negative-tangible-book must bite) — falsification test: clean resolution of the CIDs and antitrust suit, no breach, and continued investment-grade delevering.
15. Source Appendix
See the Source Appendix below for the full primary-source list. Principal sources: Equifax FY2021–FY2025 Forms 10-K (CIK 0000033185; FY25 filed 2026-02-19), FY2025–Q1’26 Forms 10-Q and 8-K, the DEF 14A proxy (filed 2026-03-27), and the SEC Form 4 corpus; Q2’25–Q1’26 earnings-call transcripts (2025-07-22, 2025-10-21, 2026-02-04, 2026-04-21); public financial-statement and ratio data; published valuation and price history; and a public factor model. All non-obvious facts are cited with source and date in the appendix.
APPENDIX A — Standard Diligence Questionnaire
Equifax Inc. (NYSE: EFX) · Report date 2026-06-27 · Supplemental to the research memo. Fact / Interpretation / Assumption labels applied where it matters.
General
What thoughtful questions have other investors asked about this company? The dominant debate is cyclical-versus-structural: is Workforce Solutions’ deceleration from a 13–15% secular grower to a +5% trough (Q3’25) a mortgage/hiring-cycle artifact or the maturing of The Work Number? Other recurring questions: how much of recent Workforce “growth” is zero-margin FICO pass-through versus real share gains; whether the EFX Cloud FCF inflection is durable or just a capex-timing blip; whether Experian Verify is a genuine threat to the 44%-margin crown jewel; and whether the ~47% drawdown has over-corrected a still-elite franchise. (Interpretation, from transcripts and sell-side notes.)
Cyclicality & Earnings Nature
Are earnings at a cyclical high or low? Low. (Fact) U.S. mortgage inquiries are down >50% versus the 2015–19 average; talent/hiring verticals are below plan; and reported margin is depressed by the cloud-amortization tail. Management sizes a full mortgage recovery at +$1.2B revenue and >$5.75 of incremental adjusted EPS — i.e., current earnings sit well below mid-cycle.
Driven by the external environment or internal actions? Both. (Interpretation) Externally, the rate-shock mortgage depression and a soft hiring market. Internally, the multi-year EFX Cloud build that compressed margin and capex, now rolling off and inflecting FCF.
How stable are revenues? Moderately stable — overwhelmingly transactional/subscription on proprietary data, but the highest-incremental-margin lines (online queries, mortgage) flex hard with the credit cycle (Workforce went +14% FY22 → flat FY23). (Fact)
Outlook for products/services; how big will this market be? Growing. (Fact/Assumption) Management’s medium-term framework is 7–10% organic revenue; the government verification TAM is ~$5B and is positioned to inflect on 2025 legislation; The Work Number addresses ~250M income-producing Americans against ~211M records. International is the laggard.
Business Quality & Competitive Moat
Is the industry getting more or less competitive? More, at the margin. (Fact/Interpretation) The bureau data layer remains a durable three-firm oligopoly, but verification (the highest-return segment) faces Experian Verify replicating the model plus consumer-permissioned fintech entrants.
How profitable is the business (ROIC, ROE)? Consolidated GAAP ROIC ~8.2%, ROE ~10.2% (FY25) — roughly at the cost of capital, depressed by ~$6.7B goodwill and the cloud bulge. (Fact) Segment economics are franchise-grade: Workforce 44.2% and USIS 22.9% operating margins. The gap between mediocre consolidated returns and elite segment margins is the key analytical point.
How profitable is the industry — competitors, barriers? High barriers (data cooperative, FCRA compliance, scale), three national bureaus. (Fact) Experian and TransUnion are the direct peers; Experian is the larger, more diversified bureau and the verification challenger.
Can the business be easily understood? Mostly — three segments, transactional data products. (Interpretation) The complexity is in the FICO pass-through optics and adjusted-vs-GAAP bridge.
Can it be undermined by foreign low-cost labor? No. (Fact) The moat is proprietary U.S. data and regulatory position, not labor cost.
Do brands matter? Switching costs? The Work Number and the Equifax bureau name carry standard-setting weight; switching costs are real but asymmetric — high for the data cooperative, low for the verification service (the 10-K’s own admission). (Fact/Interpretation)
Financial Condition & Balance Sheet
Assets not fully recognized on the balance sheet? Yes — the proprietary data assets (The Work Number records, credit files) are largely internally generated and under-stated; offset by ~$6.7B goodwill that overstates the asset base. (Interpretation)
Off-balance-sheet liabilities? None material flagged; standard operating leases and litigation contingencies (CFPB CIDs, antitrust suit). (Fact)
How conservative is the accounting? Mixed. (Interpretation) The capitalized-internal-use-software policy (~$3.1B gross, ~$281M added in FY25) defers development cost off the income statement and flatters adjusted EBITDA; the recurring “restructuring” add-back (5+ years) strains the one-time label. True FCF validates the cash, which tempers the concern.
How CapEx-hungry is the business? Was very (12.2% of revenue at the FY22 peak); now normalizing to 7.9% and falling as the cloud build completes. (Fact) Structurally a moderate-capex data business.
Capital Allocation & Management
How much FCF, and how is it used? ~$1.13B true FCF (FY25, 172% of GAAP NI). (Fact) Used for dividends (~$233M), buybacks (~$928M FY25, the first real buyback since 2017), debt paydown, and bolt-on M&A.
Significant acquisitions recently? Kount ($640M, 2021), Appriss Insights ($1.825B, 2021), Boa Vista (~$580M, 2023), Vault Verify (2025). (Fact) Richly priced into a cyclical peak — the ~$6.7B goodwill and ~8% ROIC are the bill. (Interpretation)
Buying back shares? Yes, newly — $927.5M in FY25 under a $3B authorization (April 2025); shares 124.0M → 120.4M. (Fact)
Issuing large amounts of stock to insiders? No — SBC is modest (~$78M, ~1.3% of revenue). (Fact)
Compensation policy / motivations of management? Annual plan on operating revenue + adjusted EPS; LTI on relative TSR + absolute adjusted EBITDA. No return-on-capital metric anywhere — a structural flag that rewards growth over capital efficiency. (Fact) CEO Begor comp $23.4M FY25. Insiders are net sellers (one ~$465K open-market buy versus 54 sells in 18 months). (Fact)
Valuation & Market Data
ADR, MLP, or K-1 issuer? No — a U.S. C-corporation; standard 1099 dividend. (Fact)
Dividend policy? $0.56/quarter (raised +12% in March 2026, after +28% in April 2025); ~35% GAAP payout, ~1.3–1.4% yield; frozen 2017–2024 during the breach paydown. (Fact)
How profitable is the business? See above — elite at the segment level, value-neutral at the consolidated GAAP-return level. (Fact)
Is net income diverging from cash from operations? Yes, favorably — CFO is ~2.4x net income (D&A-heavy), and true FCF is ~1.7x GAAP NI. (Fact) The divergence is the capitalized-software/D&A dynamic, not a red flag.
Risks & Downside
What would cause the stock to decline? A durable Workforce deceleration proving structural; mortgage staying depressed through the next easing cycle; an adverse CFPB/antitrust outcome; a data breach; a further multiple de-rate in a risk-off tape (beta 1.40). (Fact/Interpretation)
Risk of catastrophic loss? Low-probability but real — a 2017-style breach for a company that is its data, with negative tangible book and no asset cushion, is the genuine tail. (Interpretation)
Chance of a total loss? Very low. (Interpretation) Investment-grade balance sheet, ~$1.1B FCF, durable oligopoly position. Total loss would require a catastrophic, trust-destroying event plus the leverage biting — improbable but not zero.
Recent News & Events
Has the business environment changed recently? Yes — the FHFA’s July-2025 VantageScore approval (a tailwind for the bureaus); the One Big Beautiful Bill (July 2025) creating government-verification demand; the cloud build reaching “substantially complete”; and an early-2026 AI-disintermediation selloff. (Fact)
Significant acquisitions / accounting changes / new markets? Bolt-on Vault Verify (Q4’25); no accounting-policy changes flagged; new USIS and International leadership in 2026; the capital-return ramp (buyback + two dividend hikes). (Fact)
APPENDIX B — Source Appendix
Equifax Inc. (NYSE: EFX) · CIK 0000033185 · Report date 2026-06-27 · Price reference $158.48 (2026-06-26). Primary sources prioritized; all non-obvious facts traceable to a research-log entry.
Primary — SEC filings (EDGAR, CIK 0000033185)
- Form 10-K, FY2025 (filed 2026-02-19,
efx-20251231.htm) — Item 1 Business (segments, The Work Number records/contributors, competition); MD&A segment revenue/operating-margin tables; PP&E and capitalized-internal-use-software notes; debt schedule; risk factors (2017 breach, FCRA/CFPB, verification competition). Principal source for FY25 segment economics, margins, and balance sheet. - Forms 10-K, FY2021–FY2024 (filed 2022-02-24, 2023-02-23, 2024-02-22, 2025-02-20) — five-year revenue/margin history; M&A disclosures (Kount, Appriss Insights, Boa Vista); 2017-breach charge history (Consumer Restitution Fund $380.5M).
- Forms 10-Q, FY2025–Q1’26 and 8-K earnings releases — quarterly segment growth cadence, FY26 guidance, capital-return actions.
- DEF 14A proxy (filed 2026-03-27) — executive-compensation metrics (operating revenue + adjusted EPS annual; relative TSR + absolute adjusted EBITDA LTI; no return-on-capital metric); CEO Begor FY25 total comp $23.4M.
- Form 4 corpus (trailing 18 months, 94 filings / 190 transaction lines) — insider activity: one open-market purchase (director Cecilia Mao ~$465K, Feb 2026) vs 54 sales; CEO Begor zero open-market buys.
Primary — Earnings-call transcripts
- Q1 2026 (2026-04-21) — revenue +14%, organic cc +13%, adjusted EPS $1.86 (+22%), U.S. mortgage +38%, Vitality Index 17%; “would have raised” guidance absent Iran-conflict uncertainty; Verification +14%.
- Q4 2025 (2026-02-04) — FY26 guidance (revenue ~$6.745B, adjusted EPS $8.50, FCF >$1.0B, ex-FICO margin +75bps); FICO pass-through framing (“100 miles away”); mortgage-recovery sizing (+$1.2B / +$5.75 EPS); AI-moat defense.
- Q3 2025 (2025-10-21) — guidance raised; Workforce +5% trough context.
- Q2 2025 (2025-07-22) — guidance held-despite-beat; Workforce FY outlook cut to ~+5%; corporate expense raised to ~$590M.
- Investor Day (June 2025) — 2030 scenarios (base ~$9.6B / ~$15 adj EPS; mortgage-recovery ~$10.8B / ~$19 adj EPS); “rule of ~50” framework.
Quantitative data sources
- Financial statements & ratios — income statement, balance sheet, cash flow, profitability/valuation ratios, and enterprise value (FY2020–FY2025), reconciled to filings. (Note: aggregator “free cash flow” fields that equal CFO and do not subtract capex were overridden — true FCF computed as CFO − capex; reported EV/multiples reflecting a stale higher market cap were recomputed at spot.)
- Valuation & price history — own-history valuation percentiles (composite 9.8th; P/E 19.0th; P/B 9.6th; P/S 0.66th) and the five-year daily OHLCV price series (ATH $302.01 on 2024-09-13; 52wk range $151.93–$262.95).
- Published sell-side actions — UBS Buy PT $215 (2026-06-16) and Wells Fargo Overweight PT $220 (2026-06-18).
- Factor model — loadings (Market 1.40 beta; Real Estate 0.52; Value 0.23; Momentum −0.33; InterestRate −0.20), risk-adjusted track record (negative Sharpe all horizons; y1 −1.07), and factor-similar peers (SSNC, SPGI, ADP, TYL, FSV).
Notes on labeling
Management commentary (transcripts, Investor Day) is treated as hypothesis and validated against filings and external data. Forward figures (the mortgage-recovery EPS bridge, VantageScore EBITDA, the 2030 scenarios) are management-sourced and labeled Assumption where carried into the analysis. Scenario valuations above are analyst illustrations, not price targets.